Search results
Results from the WOW.Com Content Network
This fund is benchmarked to the MSCI Emerging Markets ex China index, which tracks large- and mid-cap companies in emerging market nations, excluding China. 2024 YTD performance: 12.9% Historical ...
Perrigo Company plc (Hebrew: פריגו) is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales.
WuXi Biologics has two sites located in Wu Xi City, China. The Mashan site contains MFG1, MFG2, MFG4 and MFG5. [14] and the Wuxi New Area site contains labs dedicated to the antibody drug conjugate development and production. With 30,000 liters of capacity, MFG2 was the world's largest single-use bioreactor production facility which was ...
The Quality of drugs and Active Pharmaceutical Ingredients (API) made by Chinese pharmaceutical companies is often poor. In the past three years 2015–2017, there were 35 FDA warning letters to Chinese pharmaceutical companies citing serious Data Integrity issues, including data deletion or manipulation or fabrication of test results, see "An Analysis of 2017 FDA Warning Letters on Data ...
In July 2020, STAR hit a record level in the value of new listings. [3] Companies raised more than US$7 billion in July 2020, a 46% increase compared with July 2019. [3] Notable listings in July 2020 included publicly-held semiconductor manufacturer SMIC, which was China's biggest share sale in a decade. [3]
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Li Yimei is the CEO of the company. [3] Power Corporation acquired a stake in China Asset Management in 2011, which is followed by another stake purchase by Mackenzie Investments in 2017. [4] Mackenzie is owned by Toronto-listed asset and wealth manager IGM Financial, which is owned by Power Corporation. Together they own 27.8% stake in ...
Eisai has also collaborated with a major Chinese medical insurance firm to plan partial coverage of the drug cost, the companies said without naming the insurer. China approved the treatment in ...